$CBIS a U.S. company specializing in the development of cannabis-based medicines, has kicked off its participation in the Global Health Catalyst (GHC) Summit at Harvard Medical School.
(0)
(0)
Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!